Skip to main content

Gene therapy reverses muscular dystrophy symptoms in dogs

As difficult as it is when our beloved pet dogs get old, it’s a whole lot worse if their decline is the result of a horrible disease like Duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle degeneration and weakness. Fortunately, a team of gene-editing researchers from France and the U.K. have been working to develop gene therapy as an answer — and it’s one that could help humans, too.

Their solution involves using gene therapy to restore muscle strength and stabilize clinical symptoms. This is achieved by way of a shortened version of the dystrophin gene, containing just 4,000 base pairs, which is combined with a viral vector and injected into patients.

“Duchenne muscular dystrophy is a debilitating muscle-wasting disease affecting young boys and male animals, which is caused by inheritance of a damaged gene,” George Dickson, professor of molecular cell biology at University of London, told Digital Trends. “There is currently no very effective cure. Our work has involved producing a healthy functioning copy of the damaged gene in the lab, and then using a harmless virus to carry the gene into the affected muscles, a so-called gene therapy.”

The gene treatment has so far been tested on twelve golden retrievers affected by Duchenne muscular dystrophy. After a single dose, the dogs’ dystrophin production — the protein responsible for maintaining the integrity and strength of muscles — returned to its normal levels. Best of all, the trial was carried out a few years back, and all signs point to this being a lasting treatment. A paper describing the work was recently published in the journal Nature Communications.

“We now have treated a number of dogs affected by this condition with a single round of gene therapy,” Dickson continued. “At the correct dose, the results have been very encouraging with dogs looking very active and healthy over 3 years after the treatment. The treatment involves a simple intravenous infusion, a one-off treatment, and we have been very pleased and quite surprised at how effective the gene therapy has been given that muscle is a major tissue spread all over the body.”

Next up, the researchers hope to extrapolate the findings to human children, since they they are roughly the same weight and display similar clinical symptoms to canines.

“The goal is to expand this gene therapy treatment into human patients, boys suffering from the Duchenne muscular dystrophy disease,” Dickson said. “We have to scale up production of the gene therapy medicine for human use, complete more safety tests, and then embark on recruiting patients into full-scale clinical trials.”

Should all go according to plan, it’ll be another reminder of why gene therapy is the future of medicine as we know it.

Editors' Recommendations

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Meet the game-changing pitching robot that can perfectly mimic any human throw
baseball hitter swings and misses

Who’s your favorite baseball pitcher? Shane McClanahan? Sandy Alcantara? Justin Verlander? Whoever you said, two of the top sports-tech companies in the U.S. -- Rapsodo and Trajekt Sports -- have teamed up to build a robot version of them, and the results are reportedly uncannily accurate.

Okay, so we’re not talking about walking-talking-pitching standalone robots, as great a sci-fi-tinged MLB ad as that would be. However, Rapsodo and Trajekt have combined their considerable powers to throw a slew of different technologies at the problem of building a machine that's able to accurately simulate the pitching style of whichever player you want to practice batting against -- and they may just have pulled it off, too.

Read more
The best portable power stations
EcoFlow DELTA 2 on table at campsite for quick charging.

Affordable and efficient portable power is a necessity these days, keeping our electronic devices operational while on the go. But there are literally dozens of options to choose from, making it abundantly difficult to decide which mobile charging solution is best for you. We've sorted through countless portable power options and came up with six of the best portable power stations to keep your smartphones, tablets, laptops, and other gadgets functioning while living off the grid.
The best overall: Jackery Explorer 1000

Jackery has been a mainstay in the portable power market for several years, and today, the company continues to set the standard. With three AC outlets, two USB-A, and two USB-C plugs, you'll have plenty of options for keeping your gadgets charged.

Read more
CES 2023: HD Hyundai’s Avikus is an A.I. for autonomous boat and marine navigation
Demonstration of NeuBoat level 2 autonomous navigation system at the Fort Lauderdale International Boat Show

This content was produced in partnership with HD Hyundai.
Autonomous vehicle navigation technology is certainly nothing new and has been in the works for the better part of a decade at this point. But one of the most common forms we see and hear about is the type used to control steering in road-based vehicles. That's not the only place where technology can make a huge difference. Autonomous driving systems can offer incredible benefits to boats and marine vehicles, too, which is precisely why HD Hyundai has unveiled its Avikus AI technology -- for marine and watercraft vehicles.

More recently, HD Hyundai participated in the Fort Lauderdale International Boat Show, to demo its NeuBoat level 2 autonomous navigation system for recreational boats. The name mashes together the words "neuron" and "boat" and is quite fitting since the Avikus' A.I. navigation tech is a core component of the solution, it will handle self-recognition, real-time decisions, and controls when on the water. Of course, there are a lot of things happening behind the scenes with HD Hyundai's autonomous navigation solution, which we'll dive into below -- HD Hyundai will also be introducing more about the tech at CES 2023.

Read more